Teva to Report First Quarter 2016 Financial Results on May 9, 2016
Teva Pharmaceutical Industries Ltd announced that it will release its first quarter 2016 financial results...
Teva to Report First Quarter 2016 Financial Results on May 9, 2016
Teva Pharmaceutical Industries Ltd. announced that it will release its first quarter 2016 financial results...
Lilly To Provide Detailed Update Of Pipeline And R&D Strategy At Upcoming Investment Community...
Eli Lilly and Company announced it will host a meeting for the investment community, including...
INNATE PHARMA IN-LICENSES OREGA BIOTECH’S FIRST-IN-CLASS ANTI-CD39 CHECKPOINT INHIBITOR PROGRAM
This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the...
CTI BioPharma Announces $15.7 Million Registered Direct Offering
CTI BioPharma Corp. announced that it has entered into an agreement with institutional investors to...
Seattle Genetics, BMS to evaluate Adcetris and Opdivo combination
Seattle Genetics and Bristol-Myers Squibb (BMS) have entered into a clinical trial collaboration agreement to...
Ireland’s Shire to acquire NPS Pharmaceuticals for $5.2bn
Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn....
Pfizer acquires Baxter’s marketed vaccines portfolio for $635m
US-based drug maker Pfizer has completed the acquisition of marketed vaccines portfolio from Baxter International...
Johnson & Johnson completes acquisition of AliosBioPharma for $1.75bn
US-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage...
Aegerion to acquire AstraZeneca’s lipodystrophy treatment Myalept for $325m
Aegerion Pharmaceuticals has signed an agreement to acquire an orphan product Myalept (metreleptin for injection)...
